Advertisement

Ethical Considerations

  • Dorothee HorstkötterEmail author
  • Guido de Wert
Chapter
  • 11 Downloads

Abstract

Since its first applications in humans, DBS has triggered a plethora of ethical questions and concerns and stimulated extensive ethical debates as to its significance and desirability. The main ethical goal is to guide and support responsible decision-making in clinical DBS treatment, as well as related medical research, and to raise awareness about salient ethical issues.

Traditional medical ethics consists of the three basic principles of respect for autonomy, beneficence/nonmaleficence and justice. In the context of DBS, these principles require specific attention as to what exactly it means to “respect autonomy,” to safeguard beneficence and nonmaleficence, and to live up to the requirements of justice. Taking the risks and side effects of DBS into account and comparing this treatment to possible alternative treatments is crucial. Given the increasing interest in applying DBS to psychiatric disorders, research ethical questions have been put on the agenda. The status of the brain also gave rise to the expression of profound ethical concerns, particularly regarding potential changes in patients’ personal identity. However, different understandings of this very concept lead to diverging evaluations of the ethical value of potentially identity-modifying techniques. Independent ethical substudies or integral add-on projects in DBS research can advance systematic ethical thought regarding ongoing research endeavors and upcoming new applications.

Keywords

Deep brain stimulation Medical ethics Research ethics Autonomy Beneficence Neuroethics Personal identity Self-estrangement Experimental treatment Ethical add-on research 

References

  1. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987;17:20–4.PubMedCrossRefPubMedCentralGoogle Scholar
  2. Baylis F. ‘I Am Who I Am’. On the perceived threats to personal identity from deep brain stimulation. Neuroethics. 2013;6:513–26.PubMedCrossRefPubMedCentralGoogle Scholar
  3. Baylis F. Neuroethics and identity. In: Clausen J, Levy N, editors. Handbook of neuroethics. Dordrecht: Springer Science; 2015. p. 367–72.Google Scholar
  4. Beauchamp TL, Childress JF. Principles of biomedical ethics. 6th ed. Oxford: Oxford University Press; 2009.Google Scholar
  5. Beeker T, Schlaepfer TE, Coenen VA. Autonomy in depressive patients undergoing DBS-treatment: informed consent, freedom of will and DBS’ potential to restore it. Front Integr Neurosci. 2017;11:11.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Bell E, Mathieu G, Racine E. Preparing the ethical future of deep brain stimulation. Surg Neurol. 2009;72:577–86.PubMedCrossRefPubMedCentralGoogle Scholar
  7. Bransen J. Alternatives of oneself: recasting some of our practical problems. Philos Phenomenol Res. 2000;60:381–400.CrossRefGoogle Scholar
  8. Carter A, Bell E, Racine E, Hall W. Ethical issues raised by proposals to treat addiction using deep brain stimulation. Neuroethics. 2011;4:129–42.CrossRefGoogle Scholar
  9. Christopher PP, Dunn LB. Risk and consent in neuropsychiatric deep brain stimulation: an exemplary analysis of treatment-resistant depression, obsessive-compulsive disorder, and dementia. In: Clausen J, Levy N, editors. Handbook of neuroethics. Dordrecht: Springer Science; 2015. p. 589–605.Google Scholar
  10. Clair A-H, Haynes W, Mallet L. Recent advances in deep brain stimulation in psychiatric disorders. F1000 Res. 2018;7:699.CrossRefGoogle Scholar
  11. Clausen J. Ethical brain stimulation—neuroethics of deep brain stimulation in research and clinical practice. Eur J Neurosci. 2010;32:1152–62.PubMedCrossRefPubMedCentralGoogle Scholar
  12. De Haan S, Rietveld E, Stokhof M, Denys D. The phenomenology of deep brain stimulation-induced changes in OCD: an enactive affordance-based model. Front Hum Neurosci. 2013;7:653.  https://doi.org/10.3389/fnhum.2013.00653.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Dunn LB, Holtzheimer PE, Hoop JG, et al. Ethical issues in deep brain stimulation research for treatment-resistant depression: focus on risk and consent. AJOB Neurosci. 2011;2:29–36.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267:2221–6.PubMedCrossRefPubMedCentralGoogle Scholar
  15. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701–11.PubMedCrossRefPubMedCentralGoogle Scholar
  16. Fins JJ, Mayberg HS, Nuttin B, et al. Misuse of the FDA’s humanitarian device exemption In deep brain stimulation for obsessive-compulsive disorder. Health Aff. 2011;30:302–11.CrossRefGoogle Scholar
  17. Focquaert F, Schermer M. Moral enhancement: do means matter morally? Neuroethics. 2015;8:139–51.CrossRefGoogle Scholar
  18. Galert T. Impact of brain interventions on personal identity. In: Clausen J, Levy N, editors. Handbook of neuroethics. Dordrecht: Springer Science; 2015. p. 407–22.Google Scholar
  19. Gilbert F. The burden of normality: from ‘chronically ill’ to ‘symptom free’. New ethical challenges for deep brain stimulation postoperative treatment. J Med Ethics. 2012;8:408–12.CrossRefGoogle Scholar
  20. Gilbert F. Deep brain stimulation: inducing self-estrangement. Neuroethics. 2018;11:157–65.CrossRefGoogle Scholar
  21. Gilbert F, Ovadia D. Deep brain stimulation in the media: over-optimistic portrayals call for a new strategy involving journalists and scientists in ethical debates. Front Integr Neurosci. 2011;5:16.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Gilbert F, Goddard E, Viaña JNM, et al. I miss being me: phenomenological effects of deep brain stimulation. AJOB Neurosci. 2017;8:96–109.CrossRefGoogle Scholar
  23. Gilbert F, Viaña JNM, Ineichen C. Deflating the ‘DBS causes personality changes’ bubble. Neuroethics. 2018:1–17.  https://doi.org/10.1007/s12152-018-9373-8.
  24. Glannon W. Deep-brain stimulation for depression. HEC Forum. 2008;20:325–35.  https://doi.org/10.1007/s10730-008-9084-3.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Glannon W. Stimulating brains, altering minds. J Med Ethics. 2009;35:289–92.PubMedCrossRefPubMedCentralGoogle Scholar
  26. Glannon W. Consent to deep brain stimulation for neurological and psychiatric disorders. J Clin Ethics. 2010;21:104–11.PubMedPubMedCentralGoogle Scholar
  27. Goering S, Klein E, Dougherty DD, Widge AS. Staying in the loop: relational agency and identity in next-generation DBS for psychiatry. AJOB Neurosci. 2017;8:59–70.CrossRefGoogle Scholar
  28. Guideline for Good Clinical Practices of the ICH. ICH International Council for harmonisation of technical requirements for pharmaceuticals for human use. Integrated Addendum to ICH E6 (R1): Guideline for good clinical practice 2016. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4_2016_1109.pdf. Accessed 30 Sept 2018.
  29. Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci. 2011;34:289–307.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Johansson V, Garwicz M, Kanje M, et al. Beyond blind optimism and unfounded fears: deep brain stimulation for treatment resistant depression. Neuroethics. 2013;6:457–71.CrossRefGoogle Scholar
  31. Johansson V, Garwicz M, Kanje M, et al. Thinking ahead on deep brain stimulation: an analysis of the ethical implications of a developing technology. AJOB Neurosci. 2014;5:24–33.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Kraemer F. Authenticity or autonomy? When deep brain stimulation causes a dilemma. J Med Ethics. 2013;39:757–60.PubMedCrossRefPubMedCentralGoogle Scholar
  33. Kramer PD. Listening to Prozac. A psychiatrist explores antidepressant drugs and the remaking of the self. New York: Penguin Books; 1993.Google Scholar
  34. Kubu CS, Ford PJ. Clinical ethics in the context of deep brain stimulation for movement disorders. Arch Clin Neuropsychol. 2017;32:829–39.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Kuhn J, Gaebel W, Klosterkoetter J, Woopen C. Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. Eur Arch Psychiatry Clin Neurosci. 2009;259:S135–41.PubMedCrossRefPubMedCentralGoogle Scholar
  36. Leentjens AF, Visser Vandewalle V, Temel Y, Verhey F. Manipuleerbare wilsbekwaamheid: een ethisch probleem bij elektrostimulatie van de nucleus subthalamicus voor ernstige ziekte van Parkinson. [Manipulation of mental competence: an ethical problem in case of electrical stimulation of the subthalamic nucleus for severe Parkinson’s disease]. Ned Tijschr Geneeskd. 2004;148:1394–8.Google Scholar
  37. Leentjens AF, Horstkötter D, De Wert G. Ethische overwegingen bij de behandeling met diepe hersenstimulaties [Ethical considerations in treatments with deep brain stimulation]. In: Temel Y, Leentjens AF, de Bie RM, editors. Handboek diepe hersenstimulatie bij neurologische en psychiatrische aandoeningen. Houten: Bohn Stafleu van Loghum; 2016. p. 67–75.Google Scholar
  38. Lipsman N, Bernstein M, Lozano AM. Criteria for the ethical conduct of psychiatric neurosurgery clinical trials. Neurosurg Focus. 2010;29:E9.PubMedCrossRefGoogle Scholar
  39. Martinez-Ramirez D, Jimenez-Shahed J, Leckman JF, et al. Efficacy and safety of deep brain stimulation in Tourette syndrome: the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry. JAMA Neurol. 2018;75:353–9.PubMedPubMedCentralCrossRefGoogle Scholar
  40. Müller S, Christen M. Deep brain stimulation in Parkinsonian patients—ethical evaluation of cognitive, affective, and behavioral sequelae. AJOB Neurosci. 2011;2:3–13.CrossRefGoogle Scholar
  41. Müller S, Riedmüller R, Walter H, Christen M. An ethical evaluation of stereotactic neurosurgery for anorexia nervosa. AJOB Neurosci. 2015;6:50–65.CrossRefGoogle Scholar
  42. Müller S, Bittlinger M, Walter H. Threats to neurosurgical patients posed by the personal identity debate. Neuroethics. 2017;10:299–310.CrossRefGoogle Scholar
  43. Nuffield Council on Bioethics. Novel neurotechnologies: intervening in the brain. London: Nuffield Council on Bioethics; 2013.Google Scholar
  44. Nuttin B, Wu H, Mayberg H, et al. Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders. J Neurol Neurosurg Psychiatry. 2014;85:1003.PubMedPubMedCentralCrossRefGoogle Scholar
  45. Pacholczyk A. DBS makes you feel good!—why some of the ethical objections to the use of DBS for neuropsychiatric disorders and enhancement are not convincing. Front Integr Neurosci. 2011;5:14.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Park RJ, Singh I, Pike AC, Tan JOA. Deep brain stimulation in anorexia nervosa: hope for the hopeless or exploitation of the vulnerable? The Oxford Neuroethics Gold Standard Framework. Front Psych. 2017;8:44.Google Scholar
  47. Park RJ, Scaife JC, Aziz TZ. Study protocol: using deep-brain stimulation, multimodal neuroimaging and neuroethics to understand and treat severe enduring anorexia nervosa. Front Psych. 2018;9:24.CrossRefGoogle Scholar
  48. Pisapia JM, Halpern CH, Muller UJ, et al. Ethical considerations in deep brain stimulation for the treatment of addiction and overeating associated with obesity. AJOB Neurosci. 2013;4:35–46.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Pollak P. Deep brain stimulation for Parkinson’s disease—patient selection. Handb Clin Neurol. 2013;116:97–105.PubMedCrossRefPubMedCentralGoogle Scholar
  50. Rabins P, Appleby BS, Brandt J, et al. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior and thought. Arch Gen Psychiatry. 2009;66:931–7.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Salloch S, Vollmann J, Schildmann J. Ethics by opinion poll? The functions of attitudes research for normative deliberations in medical ethics. J Med Ethics. 2014;40:597–602.PubMedCrossRefPubMedCentralGoogle Scholar
  52. Schechtman MM. Philosophical reflections on narrative and deep brain stimulation. J Clin Ethics. 2010;21:133–9.PubMedPubMedCentralGoogle Scholar
  53. Schermer M. Ethical issues in deep brain stimulation. Front Integr Neurosci. 2011;5:17.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Schlaepfer TE, Fins JJ. Deep brain stimulation and the neuroethics of responsible publishing: when one is not enough. JAMA. 2010;303:775–6.PubMedCrossRefPubMedCentralGoogle Scholar
  55. Schüpbach MM. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology. 2006;66:1811–6.Google Scholar
  56. Siegel AM, Barett MS, Bhati MT. Deep brain stimulation for Alzheimer’s disease: ethical challenges for clinical research. J Alzheimers Dis. 2017;56:429–39.PubMedCrossRefPubMedCentralGoogle Scholar
  57. Singh I. Not robots: children’s perspectives on authenticity, moral agency and stimulant drug treatments. J Med Ethics. 2013;39:359–66.PubMedCrossRefPubMedCentralGoogle Scholar
  58. Smeets AYJM, Duits AA, Horstkötter D, et al. Ethics of deep brain stimulation in adolescent patients with refractory Tourette syndrome: a systematic review and two case discussions. Neuroethics. 2018;11:143–55.PubMedPubMedCentralCrossRefGoogle Scholar
  59. Snoek A, de Haan S, Schermer M, Horstkötter D. On the Significance of the Identity Debate in DBS and the Need of an Inclusive Research Agenda. A Reply to Gilbert, Viaña and Ineichen. Neuroethics. 2019;1–10.  https://doi.org/10.1007/s12152-019-09411-w.
  60. Synofzik M. Deep brain stimulation research ethics: the ethical need for standardized reporting, adequate trial design, and study registrations. In: Clausen J, Levy N, editors. Handbook of neuroethics. Dordrecht: Springer Science; 2015a. p. 621–33.Google Scholar
  61. Synofzik M. Ethical implications of brain stimulation. In: Clausen J, Levy N, editors. Handbook of neuroethics. Dordrecht: Springer Science; 2015b. p. 553–60.Google Scholar
  62. Synofzik M, Schlaepfer TE. Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol J. 2008;3:1511–20.PubMedCrossRefPubMedCentralGoogle Scholar
  63. Taylor C. The concept of a person. In: Taylor C, editor. Human agency and language. Philosophical papers 1. Cambridge: Cambridge University Press; 1985. p. 97–114.CrossRefGoogle Scholar
  64. Temel Y, Hescham SA, Jahanshahi A, et al. Neuromodulation in psychiatric disorders. Int Rev Neurobiol. 2012;107:283–314.PubMedCrossRefPubMedCentralGoogle Scholar
  65. Voigt JS. Bodily felt freedom: an ethical perspective on positive aspects of deep brain stimulation. Neuroethics. 2018:1–13.  https://doi.org/10.1007/s12152-018-9380-9.
  66. Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol. 2010;6:487.PubMedCrossRefPubMedCentralGoogle Scholar
  67. Witt K, Kuhn J, Timmermann L, et al. Deep brain stimulation and the search for identity. Neuroethics. 2013;6:499–511.PubMedCrossRefPubMedCentralGoogle Scholar
  68. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. 2013. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 30 Sept 2018.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Health, Ethics and Society, School of Mental Health and Neuroscience (MHeNS)Maastricht UniversityMaastrichtThe Netherlands
  2. 2.Department of Health, Ethics and Society, Care and Public Health Research Institute (CAPHRI), School of Oncology and Developmental Biology (GROW)Maastricht UniversityMaastrichtThe Netherlands

Personalised recommendations